• The fight against Democrat fake-paper factories that churn out sham sci

    From Bradley K. Sherman@1:229/2 to All on Friday, June 04, 2021 14:07:22
    XPost: alt.politics.clinton, alt.politics.democrats, alt.news-media
    XPost: misc.survivalism
    From: bksherman@bleeding-rectums.cnn.com

    When Laura Fisher noticed striking similarities between research
    papers submitted to RSC Advances, she grew suspicious. None of
    the papers had authors or institutions in common, but their
    charts and titles looked alarmingly similar, says Fisher, the
    executive editor at the journal. “I was determined to try to get
    to the bottom of what was going on.”

    A year later, in January 2021, Fisher retracted 68 papers from
    the journal, and editors at two other Royal Society of Chemistry
    (RSC) titles retracted one each over similar suspicions; 15 are
    still under investigation. Fisher had found what seemed to be
    the products of paper mills: companies that churn out fake
    scientific manuscripts to order. All the papers came from
    authors at Chinese hospitals. The journals’ publisher, the RSC
    in London, announced in a statement that it had been the victim
    of what it believed to be “the systemic production of falsified
    research”.

    What was surprising about this was not the paper-mill activity
    itself: research-integrity sleuths have repeatedly warned that
    some scientists buy papers from third-party firms to help their
    careers. Rather, it was extraordinary that a publisher had
    publicly announced something that journals generally keep quiet
    about. “We believe that it is a paper mill, so we want to be
    open and transparent,” Fisher says.

    The RSC wasn’t alone, its statement added: “We are one of a
    number of publishers to have been affected by such activity.”
    Since last January, journals have retracted at least 370 papers
    that have been publicly linked to paper mills, an analysis by
    Nature has found, and many more retractions are expected to
    follow.

    Much of this literature cleaning has come about because, last
    year, outside sleuths publicly flagged papers that they think
    came from paper mills owing to their suspiciously similar
    features. Collectively, the lists of flagged papers total more
    than 1,000 studies, the analysis shows. Editors are so concerned
    by the issue that last September, the Committee on Publication
    Ethics (COPE), a publisher-advisory body in London, held a forum
    dedicated to discussing “systematic manipulation of the
    publishing process via paper mills”. Their guest speaker was
    Elisabeth Bik, a research-integrity analyst in California known
    for her skill in spotting duplicated images in papers, and one
    of the sleuths who posts their concerns about paper mills online.

    Bik thinks there are thousands more of these papers in the
    literature. The RSC’s announcement is significant for its
    openness, she says. “It is pretty embarrassing that so many
    papers are fake. Kudos to them to admit that they have been
    fooled.”

    At some journals that have had a spate of apparent paper-mill
    submissions, editors have now revamped their review processes,
    aiming not to be fooled again. Combating industrialized cheating
    requires stricter review: telling editors to ask for raw data,
    for instance, and hiring people specifically to check images.
    Science publishing needs a “concerted, coordinated effort to
    stamp out falsified research”, the RSC said.

    Paper-mill detectives
    In January 2020, Bik and other image detectives who work under
    pseudonyms — Smut Clyde, Morty and Tiger BB8 — posted, on a blog
    run by science journalist Leonid Schneider, a list of more than
    400 published papers they said probably came from a paper mill.
    Bik dubbed it the ‘tadpole’ paper mill, because of the shapes
    that appeared in the papers’ western blot analyses, a type of
    test used to detect proteins in biological samples. A spate of
    media headlines followed. Throughout the year, the sleuths (not
    always working together) posted spreadsheets of other suspect
    papers — picking up on similar features across multiple studies.
    By March 2021, they had collectively listed more than 1,300
    articles, by Nature’s tally, as possibly coming from paper mills.

    Journals started to look at the papers. According to Nature’s
    analysis, around 26% of the articles that the sleuths alleged
    came from paper mills have so far been retracted or labelled
    with expressions of concern. Many others are still under
    investigation. The Journal of Cellular Biochemistry (JCB), for
    instance, announced in February1 that, last year, editors
    investigated and retracted 23 of 137 papers alleged to contain
    image manipulation.

    Journals did not identify problems with all of the papers that
    had been flagged. Chris Graf, director of research integrity at
    Wiley, which publishes JCB, said in January that the publisher
    had completed investigations into 73 papers identified by Bik
    and others, and had found no reason to act on 11 of them. Seven
    others required corrections and 55 have been retracted or will
    be retracted.

    Publishers almost never explicitly declare on retraction notices
    that a particular study is fraudulent or was created by a
    company to order, because it is difficult to prove. None of the
    RSC’s retraction notices, for instance, mentions a paper mill —
    despite the RSC’s announcement that it thinks the articles did
    come from one. But Nature has tallied 370 articles retracted
    since January 2020, all from authors at Chinese hospitals, that
    either publishers or independent sleuths have alleged to come
    from paper mills (see ‘Fraud allegations’). Most were published
    in the past three years (see ‘Chinese hospital papers on the
    rise’). Publishers have added expressions of concern to another
    45 such articles.

    FRAUD ALLEGATIONS: barchart showing the number of published
    papers potentially linked to companies that produce fraudulent
    work.
    Sources: forbetterscience.com, scienceintegritydigest.com and
    Nature analysis

    Nature has identified a further 197 retractions of papers from
    authors at Chinese hospitals since the start of last year. These
    are not ones that have made it onto lists of potential
    publication-mill products, although some were flagged by sleuths
    for image concerns, often on the post-publication peer-review
    website PubPeer.

    Industrialized cheating
    The problem of organized fraud in publishing is not new, and not
    confined to China, notes Catriona Fennell, who heads publishing
    services at the world’s largest scientific publisher, Elsevier.
    “We’ve seen evidence of industrialized cheating from several
    other countries, including Iran and Russia,” she told Nature
    last year. Others have also reported on Iranian and Russian
    paper-mill activities.

    In a statement this year to Nature, Elsevier said that its
    journal editors detect and prevent the publication of thousands
    of probable paper-mill submissions each year, although some do
    get through.

    China has long been known to have a problem with firms selling
    papers to researchers, says Xiaotian Chen, a librarian at
    Bradley University in Peoria, Illinois. As far back as 2010, a
    team led by Shen Yang, a management-studies researcher then at
    Wuhan University in China, warned of websites offering to
    ghostwrite papers on fictional research, or to bypass peer-
    review systems for payment. In 2013, Science reported on a
    market for authorships on research papers in China. In 2017,
    China’s Ministry of Science and Technology (MOST) said it would
    crack down on misconduct after a scandal in which 107 papers
    were retracted at the journal Tumor Biology; their peer reviews
    had been fabricated and a MOST investigation concluded that some
    had been produced by third-party companies.

    Physicians in China are a particular target market because they
    typically need to publish research articles to gain promotions,
    but are so busy at hospitals that they might not have time to do
    the science, says Chen. Last August, the Beijing municipal
    health authority published a policy stipulating that an
    attending physician wanting to be promoted to deputy chief
    physician must have at least two first-author papers published
    in professional journals; three first-author papers are required
    to become a chief physician. These titles affect a physician’s
    salary and authority, as well as the surgeries they are allowed
    to perform, says Changqing Li, a former senior physician and
    gastroenterology researcher at a Chinese hospital who now lives
    in the United States.

    “The effect is devastating,” says Li, about the impacts on
    Chinese science. “The literature environment published in
    Chinese is already ruined, since hardly anyone believes them or
    references studies from them.”

    “Now this plague has eroded into the international medical
    journals,” he adds. The fact that people use paper mills also
    affects China’s reputation globally, says Futao Huang, a Chinese
    researcher working at Hiroshima University in Japan.

    The prevalence of problem papers is leading some journal editors
    to doubt the submissions they get from Chinese hospital
    researchers. “The increasing volume of this ‘junk science’ is
    wreaking havoc on the credibility of the research emanating out
    of China and increasingly casting doubt upon legitimate science
    from the region,” said a February 2021 editorial2 in the journal
    Molecular Therapy.

    Several other editors echo these concerns about the impact of
    paper mills. “They are undermining our confidence in the other
    manuscripts received from Chinese groups,” says Frank Redegeld,
    editor in chief of the European Journal of Pharmacology,
    published by Elsevier.

    CHINESE HOSPITAL PAPERS ON THE RISE: chart showing the rise in
    English language articles with authors from Chinese hospitals.
    Source: lens.org

    China’s science and education ministries have taken steps to
    curb problematic publication incentives. They published a notice
    last February telling research institutions — including
    hospitals — not to promote or recruit researchers solely on the
    basis of the numbers of papers they publish, and also told them
    to stop paying cash bonuses for papers. And in August, China
    announced the introduction of measures to crack down on research
    misconduct, including attempts to curb independent contractors
    who fabricate data on others’ behalf. (MOST didn’t respond to
    Nature’s request for comment on the scale of the problem or the
    impact of its measures.)

    Some Chinese researchers think these measures are beginning to
    work. Li Tang, who researches science policy at Fudan University
    in Shanghai, China, is hopeful that submissions from paper mills
    in China will fall in the future — although she notes that the
    issue isn’t confined to Chinese research.

    Redegeld says he hasn’t yet seen a decrease in the number of
    suspected paper-mill manuscripts his journal receives, which he
    estimates to be around 15 a month.

    Problem signs
    Image-integrity sleuths and journal editors have identified a
    range of features in manuscripts that could be fingerprints of a
    paper mill. “We’re wondering how we protect ourselves from
    publishing this stuff,” says Jana Christopher, an image-
    integrity analyst at the publisher FEBS Press in Heidelberg,
    Germany, who screens incoming manuscripts for a number of
    journals, and helped the RSC with its investigation.

    Potential signs of trouble include papers from different authors
    at different institutions sharing similar features: western
    blots with identical-looking backgrounds and suspiciously smooth
    outlines, titles that seem to be variations on a theme, bar
    charts with identical layouts that supposedly represent
    different experiments, or identical plots of flow cytometry
    analyses, which are used in studying cells. It seems that these
    manuscripts are produced from common templates, with words and
    images slightly tweaked to make the papers look a little
    different.

    A particular problem is biomedical articles that claim to
    investigate understudied genetic regions that might be involved
    in cancers. Jennifer Byrne, a molecular oncology researcher at
    the University of Sydney, Australia, specializes in exposing
    flawed papers of this type, by spotting that their experimental
    details sometimes list incorrect nucleotide sequences or
    reagents, so that the experiments described cannot have taken
    place. Many of these papers are probably doctored simply by
    switching around the type of cancer or the genes involved in the
    study, says Byrne, although it’s hard to prove they’re from
    paper mills. “This problem of incorrect nucleotide sequences in
    the literature is rampant,” she says.

    At last September’s COPE forum, Bik rattled off other red flags
    for editors to watch out for, including papers from Chinese

    [continued in next message]

    --- SoupGate-Win32 v1.05
    * Origin: www.darkrealms.ca (1:229/2)